Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock — Oct 11th, 2024

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this medical device maker have returned -0.6% over the past month versus the Zacks S...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

HOLX Launches BustTheMyth Campaign for Breast Health Awareness — Oct 11th, 2024

Hologic, Inc. HOLX entered the Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 18th year. As part of this annual tradition, Hologic launched a comprehensive patient education campaign named BustTheMyth. The campaign is aimed at dispelling myths about breast cancer,...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock — Oct 11th, 2024

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this medical device maker have returned -0.6% over the past month versus the Zacks S...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

HOLX Launches BustTheMyth Campaign for Breast Health Awareness — Oct 11th, 2024

Hologic, Inc. HOLX entered the Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 18th year. As part of this annual tradition, Hologic launched a comprehensive patient education campaign named BustTheMyth. The campaign is aimed at dispelling myths about breast cancer,...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock — Oct 11th, 2024

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this medical device maker have returned -0.6% over the past month versus the Zacks S...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? — Oct 12th, 2024

Let's talk about the popular Hologic, Inc. (NASDAQ:HOLX). The company's shares received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$83.64 at one point, and dropping to the lows of US$73.48. Some share price movements can g...

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments — Oct 14th, 2024

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...

Hologic (HOLX) Gains As Market Dips: What You Should Know — Oct 15th, 2024

The most recent trading session ended with Hologic (HOLX) standing at $81.66, reflecting a +0.05% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.76% for the day. At the same time, the Dow lost 0.75%, and the tech-heavy Nasdaq lo...

Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings? — Oct 21st, 2024

Hologic HOLX is set to release fourth-quarter fiscal 2024 results on Nov. 4 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fourth-quarter earnings suggests a 14.6% increase year over year to $1.02 per sh...

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health — Oct 14th, 2024

MARLBOROUGH, Mass., October 14, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the developme...